Simplex Trading’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147K | Buy |
+47,867
| New | +$207K | ﹤0.01% | 4654 |
|
|
2025
Q2 | – | Sell |
-10,427
| Closed | -$89K | – | 8603 |
|
|
2025
Q1 | $89K | Buy |
10,427
+1,429
| +16% | +$13.5K | ﹤0.01% | 5172 |
|
|
2024
Q4 | $96K | Buy |
8,998
+2,242
| +33% | +$17.2K | ﹤0.01% | 5204 |
|
|
2024
Q3 | $38K | Buy |
+6,756
| New | +$39K | ﹤0.01% | 6120 |
|
|
2024
Q1 | – | Sell |
-72,136
| Closed | -$406K | – | 8817 |
|
|
2023
Q4 | $671K | Buy |
+72,136
| New | +$497K | ﹤0.01% | 3404 |
|
|
2023
Q3 | – | Sell |
-35,867
| Closed | -$285K | – | 8631 |
|
|
2023
Q2 | $291K | Sell |
35,867
-25,338
| -41% | -$217K | ﹤0.01% | 3888 |
|
|
2023
Q1 | $524K | Buy |
+61,205
| New | +$611K | ﹤0.01% | 3215 |
|
|
2022
Q1 | – | Sell |
-11,608
| Closed | -$143K | – | 10355 |
|
|
2021
Q4 | $201K | Sell |
11,608
-11,244
| -49% | -$214K | ﹤0.01% | 5187 |
|
|
2021
Q3 | $561K | Buy |
22,852
+2,942
| +15% | +$58.6K | ﹤0.01% | 3905 |
|
|
2021
Q2 | $455K | Sell |
19,910
-5,253
| -21% | -$77.8K | ﹤0.01% | 4310 |
|
|
2021
Q1 | $0 | Sell |
25,163
-32,040
| -56% | -$350K | ﹤0.01% | 8769 |
|
|
2020
Q4 | $308K | Sell |
57,203
-27,194
| -32% | -$143K | ﹤0.01% | 4030 |
|
|
2020
Q3 | $384K | Buy |
+84,397
| New | +$363K | ﹤0.01% | 3309 |
|
|
2020
Q2 | – | Sell |
-20,803
| Closed | -$78.6K | – | 7573 |
|
|
2020
Q1 | $65K | Sell |
20,803
-59,084
| -74% | -$206K | ﹤0.01% | 4850 |
|
|
2019
Q4 | $206K | Buy |
79,887
+19,283
| +32% | +$50.6K | ﹤0.01% | 3720 |
|
|
2019
Q3 | $191K | Buy |
60,604
+39,232
| +184% | +$113K | ﹤0.01% | 3596 |
|
|
2019
Q2 | $72K | Buy |
21,372
+7,891
| +59% | +$24.5K | ﹤0.01% | 4509 |
|
|
2019
Q1 | $41K | Buy |
13,481
+6,455
| +92% | +$15.4K | ﹤0.01% | 5165 |
|
|
2018
Q4 | $10K | Buy |
7,026
+2,477
| +54% | +$5.62K | ﹤0.01% | 5830 |
|
|
2018
Q3 | $12K | Sell |
4,549
-2,093
| -32% | -$5.9K | ﹤0.01% | 6297 |
|
|
2018
Q2 | $17K | Sell |
6,642
-1,150
| -15% | -$3.21K | ﹤0.01% | 5972 |
|
|
2018
Q1 | $21K | Sell |
7,792
-11,705
| -60% | -$33.1K | ﹤0.01% | 3297 |
|
|
2017
Q4 | $62K | Buy |
19,497
+3,799
| +24% | +$15K | ﹤0.01% | 2225 |
|
|
2017
Q3 | $64K | Buy |
15,698
+15,053
| +2,334% | +$66.9K | ﹤0.01% | 2059 |
|
|
2017
Q2 | $3K | Buy |
+645
| New | +$3.73K | ﹤0.01% | 4913 |
|
|
2017
Q1 | – | Sell |
-8,271
| Closed | -$42.7K | – | 6112 |
|
|
2016
Q4 | $32K | Buy |
8,271
+5,670
| +218% | +$20.2K | ﹤0.01% | 2592 |
|
|
2016
Q3 | $9K | Buy |
2,601
+2,585
| +16,156% | +$10.9K | ﹤0.01% | 3667 |
|
|
2016
Q2 | $0 | Sell |
16
-1,162
| -99% | -$5.61K | ﹤0.01% | 5787 |
|
|
2016
Q1 | $5K | Buy |
+1,178
| New | +$5.18K | ﹤0.01% | 4042 |
|
Other funds holding AVXL
VCM
SF
VPM
Simplex Trading's AVXL Position: Q1 2026 in Review
Simplex Trading opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 47,867 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4654 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AVXL as recently as Q1 2025.
Simplex Trading first reported a position in AVXL in Q1 2016 and has held it in 29 quarters since. The position peaked at $671K in Q4 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Simplex Trading held 47,867 shares of Anavex Life Sciences worth $147K as of Q1 2026.
- Anavex Life Sciences was a new Simplex Trading position in Q1 2026.
- Anavex Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4654 holding.
- Simplex Trading first reported a position in Anavex Life Sciences in Q1 2016 and has held it in 29 quarters since.
- Simplex Trading's Anavex Life Sciences position peaked at $671K in Q4 2023.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.